Showing 1 - 1 of 1
The European Commission is considering new ways to regulate the 'substances of human origin' - including blood, plasma, and cells - used in medical procedures from transfusions and transplants to assisted reproduction. This column argues that such legislation jeopardises the interests of both...
Persistent link: https://www.econbiz.de/10014426887